Kinesin Light Chain 1 Gene Haplotypes in Three Conformational Diseases

[1]  Houeto Jean-Luc.  [Parkinson's disease]. , 2022, La Revue du praticien.

[2]  Á. J. Láruson,et al.  Genetic Variation , 2020, Population Genetics with R.

[3]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[4]  H. Vankova.  Mini Mental State , 2010 .

[5]  E. Eriksson,et al.  PITX3 polymorphism is associated with early onset Parkinson's disease , 2010, Neurobiology of Aging.

[6]  Thomas W. Mühleisen,et al.  Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease , 2009, Nature Genetics.

[7]  L. Kiemeney,et al.  Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.

[8]  Nick C Fox,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.

[9]  Andrew J. Saykin,et al.  Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease , 2009, PloS one.

[10]  Concepción Lillo,et al.  Axonal Stress Kinase Activation and Tau Misbehavior Induced by Kinesin-1 Transport Defects , 2009, The Journal of Neuroscience.

[11]  A. Kondacs,et al.  Gene-environmental effects behind leukoaraiosis: a silent genetic variant of the kinesin protein can be activated in a subject with poorly controlled long-lasting hypertension. , 2009, Clinical biochemistry.

[12]  V. Pankratz,et al.  Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease , 2009, Nature Genetics.

[13]  Eden R Martin,et al.  Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. , 2009, American journal of human genetics.

[14]  K. Doheny,et al.  Genomewide association study for susceptibility genes contributing to familial Parkinson disease , 2009, Human Genetics.

[15]  S E Poduslo,et al.  Genome screen of late‐onset Alzheimer's extended pedigrees identifies TRPC4AP by haplotype analysis , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[16]  Christoph Lange,et al.  Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. , 2008, American journal of human genetics.

[17]  Mostafa Ronaghi,et al.  Whole genome survey of coding SNPs reveals a reproducible pathway determinant of Parkinson disease , 2008, Human mutation.

[18]  O. Sydow,et al.  Cerebellar αsynuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  S. Cichon,et al.  A genome-wide association study for late-onset Alzheimer's disease using DNA pooling , 2008 .

[20]  Nobutaka Hirokawa,et al.  Intracellular Transport and Kinesin Superfamily Proteins, Kifs: Structure, Function, and Dynamics , 2022 .

[21]  K. Taylor,et al.  Genome-Wide Association , 2007, Diabetes.

[22]  A. Kondacs,et al.  A Cytoskeleton Motor Protein Genetic Variant May Exert a Protective Effect on the Occurrence of Multiple Sclerosis: The Janus Face of the Kinesin Light-Chain 1 56836CC Genetic Variant , 2007, NeuroMolecular Medicine.

[23]  K. Blennow,et al.  Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease. , 2007, International journal of molecular medicine.

[24]  A. Kondacs,et al.  A Genetic Variant in Cytoskeleton Motors Amplifies Susceptibility to Leukoaraiosis in Hypertensive Smokers: Gene–Environmental Interactions Behind Vascular White Matter Demyelinization , 2007, Journal of Molecular Neuroscience.

[25]  K. Blennow,et al.  Variability in the kinesin light chain 1 gene may influence risk of age-related cataract , 2007, Molecular vision.

[26]  Winnie S. Liang,et al.  GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers , 2007, Neuron.

[27]  Rebecca F. Halperin,et al.  A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. , 2007, The Journal of clinical psychiatry.

[28]  M. Gill,et al.  Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. , 2007, Human molecular genetics.

[29]  R. Llinás,et al.  1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C , 2007, Proceedings of the National Academy of Sciences.

[30]  Sonja W. Scholz,et al.  Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data , 2006, The Lancet Neurology.

[31]  F. Scholz.  Maximum Likelihood Estimation , 2006 .

[32]  Christopher Sorensen,et al.  Role of short-range protein interactions in lens opacifications. , 2006, Molecular vision.

[33]  R. Carrell.  Cell toxicity and conformational disease. , 2005, Trends in cell biology.

[34]  Mariza de Andrade,et al.  High-resolution whole-genome association study of Parkinson disease. , 2005, American journal of human genetics.

[35]  W. Noble,et al.  Molecular motors implicated in the axonal transport of tau and α-synuclein , 2005, Journal of Cell Science.

[36]  E. Masliah,et al.  Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease , 2005, Science.

[37]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[38]  Bin Zhang,et al.  Axonal transport defects: a common theme in neurodegenerative diseases , 2005, Acta Neuropathologica.

[39]  H. Kao,et al.  Synapsin and synaptic vesicle protein expression during embryonic and post-natal lens fiber cell differentiation. , 2004, Molecular vision.

[40]  A. Delacourte,et al.  Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's disease , 2004, Neuroscience Letters.

[41]  L. Goldstein,et al.  Microtubule-dependent transport in neurons: steps towards an understanding of regulation, function and dysfunction. , 2004, Current opinion in cell biology.

[42]  Toshihiro Tanaka.  The International HapMap Project , 2003, Nature.

[43]  W. Lo,et al.  Microtubule configuration and membranous vesicle transport in elongating fiber cells of the rat lens. , 2003, Experimental eye research.

[44]  L. Goldstein,et al.  Do Disorders of Movement Cause Movement Disorders and Dementia? , 2003, Neuron.

[45]  J. Rothnagel,et al.  Alternatively Spliced Products of the Human Kinesin Light Chain 1 (KNS2) Gene , 2003, Traffic.

[46]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[47]  L. Goldstein,et al.  Kinesin-mediated axonal transport of a membrane compartment containing β-secretase and presenilin-1 requires APP , 2001, Nature.

[48]  L. Goldstein,et al.  Axonal Transport of Amyloid Precursor Protein Is Mediated by Direct Binding to the Kinesin Light Chain Subunit of Kinesin-I , 2000, Neuron.

[49]  K. Blennow,et al.  Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization , 2000, Neuroscience Letters.

[50]  C. Kaether,et al.  Axonal membrane proteins are transported in distinct carriers: a two-color video microscopy study in cultured hippocampal neurons. , 2000, Molecular biology of the cell.

[51]  K. Blennow,et al.  Standardization of measurement of β-amyloid(1-42) in cerebrospinal fluid and plasma , 2000, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[52]  K. Livak,et al.  Allelic discrimination using fluorogenic probes and the 5' nuclease assay. , 1999, Genetic analysis : biomolecular engineering.

[53]  K. Blennow,et al.  Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? , 1995, Molecular and chemical neuropathology.

[54]  L. Excoffier,et al.  Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. , 1995, Molecular biology and evolution.

[55]  K. Kosik,et al.  Inhibition of Kinesin Synthesis In Vivo Inhibits the Rapid Transport of Representative Proteins for Three Transport Vesicle Classes into the Axon , 1995, Journal of neurochemistry.

[56]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[57]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[58]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[59]  Nick C Fox,et al.  Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .

[60]  A. J. Slater,et al.  Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. , 2008, Archives of neurology.

[61]  D. Blacker,et al.  Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.

[62]  W. Noble,et al.  Molecular motors implicated in the axonal transport of tau and alpha-synuclein. , 2005, Journal of cell science.

[63]  B. Winblad,et al.  Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis , 2004, Acta Neuropathologica.

[64]  E. Kosno-Kruszewska,et al.  Degenerative axonal changes in the hippocampus and amygdala in Parkinson's disease. , 2003, Folia neuropathologica.

[65]  L. Feuk,et al.  Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation. , 2001, Genome research.

[66]  A. Lees,et al.  Parkinson's Disease Society Brain Bank, London: overview and research. , 1993, Journal of neural transmission. Supplementum.

[67]  Lees Aj,et al.  Parkinson's Disease Society Brain Bank, London: overview and research. , 1993 .